← All peptides
Healing & Recovery
Collagen & Skin
Research Chemical

GLOW Blend (BPC-157, TB-500, GHK-Cu)

Also known as: Glow Blend, GLOW, BPC-157, TB-500, GHK-Cu Blend, BPC-157 & TB-500 & GHK-Cu

GLOW is a combination research blend of BPC-157, TB-500 (Thymosin Beta-4), and GHK-Cu studied for tissue repair, recovery, and skin and connective-tissue health. Each component is an unapproved research peptide.

Last updated

Mechanism of Action

BPC-157 is a stable gastric pentadecapeptide that upregulates VEGFR2 signaling and the nitric-oxide pathway to promote angiogenesis, fibroblast migration, and tendon, ligament, and gut healing. TB-500 is the active fragment region of Thymosin Beta-4, sequestering G-actin and accelerating cell migration, blood-vessel formation, and wound closure while modulating inflammation. GHK-Cu is a copper-binding tripeptide that stimulates collagen, elastin, and glycosaminoglycan synthesis, activates antioxidant and tissue-remodeling genes, and supports dermal and wound matrix repair. Used together the components target overlapping angiogenic, anti-inflammatory, and extracellular-matrix pathways.

Half-life
Component-dependent: BPC-157 and GHK-Cu are short (minutes to a few hours), while TB-500 has a longer functional duration (days)
Administration Routes
subcutaneous
Research Status
Research Chemical

Reported Benefits

  • Studied for accelerated soft-tissue, tendon, and ligament repair
  • May support faster post-exercise and post-injury recovery in models
  • GHK-Cu component promotes collagen and elastin synthesis
  • Reported angiogenic and anti-inflammatory activity
  • Investigated for skin firmness, wound healing, and connective-tissue quality
  • Combines systemic recovery peptides with a dermal-remodeling peptide

Potential Side Effects

  • Injection-site redness, irritation, or transient pain (GHK-Cu can sting)
  • Headache, fatigue, or lightheadedness reported anecdotally
  • Possible nausea or flushing
  • Unknown long-term human safety as an unapproved blend

Common Dosing

For research use only and not medical advice: vendor research blends are commonly reconstituted to deliver roughly 250-500 mcg BPC-157, 250-500 mcg TB-500, and 1-2 mg GHK-Cu per subcutaneous administration, typically dosed several times weekly. No validated human dosing exists.

The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.

Contraindications

  • Active or history of malignancy (angiogenic activity is theoretically undesirable)
  • Known copper sensitivity or Wilson's disease (GHK-Cu component)
  • Pregnancy or breastfeeding
  • GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration

    2015

    View
  • Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications

    2016

    View
  • Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth

    2003

    View
  • Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications

    2012

    View
  • In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds

    1993

    View

It combines three research peptides: BPC-157 and TB-500 for systemic tissue repair and recovery, plus GHK-Cu for collagen synthesis and skin and connective-tissue remodeling.

Their mechanisms overlap on angiogenesis, anti-inflammation, and extracellular-matrix repair, which is why researchers study them together for recovery and skin-quality endpoints.

No. All three components are unapproved research peptides sold strictly for laboratory study, not for therapeutic use.

PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.